Shengmei Xu
Biographic Data
| ID | 10241473 |
|---|---|
| NAME | Shengmei Xu |
| GIVEN NAMES | Shengmei |
| FAMILY NAME | Xu |
| SIGNATURE | XU S |
| AFFILIATIONS | Guangzhou University of Chinese Medicine |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2025 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Zhichuanling oral liquid attenuates airway inflammation in asthma by targeting the STIM1/CHOP/JNK axis
ZCLOL alleviates airway inflammation and hyperresponsiveness in asthma by restoring Ca 2+ homeostasis and suppressing ERS through inhibition of the STIM1/CHOP/JNK axis. These findings provide mechanistic evidence supporting ZCLOL as a potential multi-target therapeutic strategy for asthma
Commentary: Perceptions and needs of patients, caregivers and health professionals regarding an oncology community center: a qualitative study
Mitnik et al.'s (2025) timely study illuminates the human dimension of decentralizing cancer care through Oncology Community Centers (OCCs). Their qualitative exploration reveals a core tension: the clash between the undeniable benefits of geographical accessibility and the deep-seated psychological need for clinical security associated with large hospitals. As healthcare systems globally grapple with rural-urban disparities, this work exposes cr…
No prominent works on this page.
Commentary: Perceptions and needs of patients, caregivers and health professionals regarding an oncology community center: a qualitative study
Mitnik et al.'s (2025) timely study illuminates the human dimension of decentralizing cancer care through Oncology Community Centers (OCCs). Their qualitative exploration reveals a core tension: the clash between the undeniable benefits of geographical accessibility and the deep-seated psychological need for clinical security associated with large hospitals. As healthcare systems globally grapple with rural-urban disparities, this work exposes cr…
Zhichuanling oral liquid attenuates airway inflammation in asthma by targeting the STIM1/CHOP/JNK axis
ZCLOL alleviates airway inflammation and hyperresponsiveness in asthma by restoring Ca 2+ homeostasis and suppressing ERS through inhibition of the STIM1/CHOP/JNK axis. These findings provide mechanistic evidence supporting ZCLOL as a potential multi-target therapeutic strategy for asthma
Airway (1 works) · Airway hyperresponsiveness (1 works) · Anxiety (1 works) · Asthma (1 works) · Bronchial hyperresponsiveness (1 works) · Existentialism (1 works) · Health care (1 works) · Healthcare Operations and Scheduling Optimization (1 works) · Homeostasis (1 works) · Inflammasome and immune disorders (1 works)